Prevalence of Hepatitis C Virus Infection Among HIV+ Men Who Have Sex with Men: a Systematic Review and Meta-analysis

Overview

Journal Int J STD AIDS

Specialty Infectious Diseases

Date 2016 Jan 31

PMID 26826159

Citations 34

Authors

Ashly E Jordan

David C Perlman

Joshua Neurer

Daniel J Smith

Don C Des Jarlais

Holly Hagan

Affiliations

Soon will be listed here.

Abstract

Since 2000, an increase in hepatitis C virus infection among HIV-infected (HIV+) men who have sex with men has been observed. Evidence points to blood exposure during sex as the medium of hepatitis C virus transmission. Hepatitis C virus prevalence among HIV + MSM overall and in relation to injection drug use is poorly characterized. In this study, a systematic review and meta-analysis examining global hepatitis C virus antibody prevalence and estimating active hepatitis C virus prevalence among HIV + MSM were conducted; 42 reports provided anti-hepatitis C virus prevalence data among HIV + MSM. Pooled prevalence produced an overall anti-hepatitis C virus prevalence among HIV + MSM of 8.1%; active HCV prevalence estimate was 5.3%-7.3%. Anti-hepatitis C virus prevalence among injection drug use and non-injection drug use HIV + MSM was 40.0% and 6.7%, respectively. Among HIV + MSM, hepatitis C virus prevalence increased significantly over time among the overall and non-injection drug use groups, and decreased significantly among injection drug use HIV + MSM. We identified a moderate prevalence of hepatitis C virus among all HIV + MSM and among non-injection drug use HIV + MSM; for both, prevalence was observed to be increasing slightly. Pooled prevalence of hepatitis C virus among HIV + MSM was higher than that observed in the 1945-1965 US birth cohort. The modest but rising hepatitis C virus prevalence among HIV + MSM suggests an opportunity to control HCV among HIV + MSM; this combined with data demonstrating a rising hepatitis C virus incidence highlights the temporal urgency to do so.

Citing Articles

Acute Hepatitis C: Current Status and Future Perspectives.

Fasano M, Ieva F, Ciarallo M, Caccianotti B, Santantonio T Viruses. 2024; 16(11).

PMID: 39599853 PMC: 11599108. DOI: 10.3390/v16111739.

Prevalence of hepatitis B and C infections among HIV-positive men who have sex with men: A systematic review and meta-analysis.

Shabil M, Yadav A, Shamim M, Ahmed M, Satapathy P, Zaidan A Health Sci Rep. 2024; 7(6):e2206.

PMID: 38933421 PMC: 11199987. DOI: 10.1002/hsr2.2206.

Injection drug use and sexually transmitted infections among men who have sex with men: A retrospective cohort study at an HIV/AIDS referral hospital in Tokyo, 2013-2022.

Ikeuchi K, Saito M, Adachi E, Koga M, Okushin K, Tsutsumi T Epidemiol Infect. 2023; 151:e195.

PMID: 37965724 PMC: 10728981. DOI: 10.1017/S0950268823001772.

Incidence and Prevalence of Hepatitis C Virus Among HIV-Negative Gay and Bisexual Men Using HIV Pre-exposure Prophylaxis (PrEP): A Systematic Review and Meta-analysis.

Traeger M, Harney B, Sacks-Davis R, Van Santen D, Cornelisse V, Wright E Open Forum Infect Dis. 2023; 10(8):ofad401.

PMID: 37593532 PMC: 10428087. DOI: 10.1093/ofid/ofad401.

The hepatitis C epidemic in Canada: An overview of recent trends in surveillance, injection drug use, harm reduction and treatment.

Lourenco L, Kelly M, Tarasuk J, Stairs K, Bryson M, Popovic N Can Commun Dis Rep. 2022; 47(12):561-570.

PMID: 35692566 PMC: 9126177. DOI: 10.14745/ccdr.v47i12a01.

References

Sulkowski M, Moore R, Mehta S, Chaisson R, Thomas D . Hepatitis C and progression of HIV disease. JAMA. 2002; 288(2):199-206. DOI: 10.1001/jama.288.2.199. View

Lee H, Ko N, Lee N, Chang C, Ko W . Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users. J Formos Med Assoc. 2008; 107(5):404-11. DOI: 10.1016/S0929-6646(08)60106-0. View

Heiligenberg M, Rijnders B, Schim van der Loeff M, de Vries H, van der Meijden W, Geerlings S . High prevalence of sexually transmitted infections in HIV-infected men during routine outpatient visits in the Netherlands. Sex Transm Dis. 2011; 39(1):8-15. DOI: 10.1097/OLQ.0b013e3182354e81. View

Amin J, Kaye M, Skidmore S, Pillay D, Cooper D, Dore G . HIV and hepatitis C coinfection within the CAESAR study. HIV Med. 2004; 5(3):174-9. DOI: 10.1111/j.1468-1293.2004.00207.x. View

Perlman D, Des Jarlais D, Feelemyer J . Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?. J Addict Dis. 2015; 34(2-3):198-205. PMC: 4550554. DOI: 10.1080/10550887.2015.1059111. View

Schmidt A, Rockstroh J, Vogel M, An der Heiden M, Baillot A, Krznaric I . Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study. PLoS One. 2011; 6(3):e17781. PMC: 3050932. DOI: 10.1371/journal.pone.0017781. View

Lansky A, Finlayson T, Johnson C, Holtzman D, Wejnert C, Mitsch A . Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections. PLoS One. 2014; 9(5):e97596. PMC: 4026524. DOI: 10.1371/journal.pone.0097596. View

Kim J, Psevdos G, Suh J, Sharp V . Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States. World J Gastroenterol. 2008; 14(43):6689-93. PMC: 2773311. DOI: 10.3748/wjg.14.6689. View

Matser A, Vanhommerig J, Schim van der Loeff M, Geskus R, de Vries H, Prins J . HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infection. PLoS One. 2013; 8(3):e57740. PMC: 3587624. DOI: 10.1371/journal.pone.0057740. View

10.

Danta M, Semmo N, Fabris P, Brown D, Pybus O, Sabin C . Impact of HIV on host-virus interactions during early hepatitis C virus infection. J Infect Dis. 2008; 197(11):1558-66. DOI: 10.1086/587843. View

11.

Gorbach P, Murphy R, Weiss R, Hucks-Ortiz C, Shoptaw S . Bridging sexual boundaries: men who have sex with men and women in a street-based sample in Los Angeles. J Urban Health. 2009; 86 Suppl 1:63-76. PMC: 2705489. DOI: 10.1007/s11524-009-9370-7. View

12.

Nelson P, Mathers B, Cowie B, Hagan H, Des Jarlais D, Horyniak D . Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791):571-83. PMC: 3285467. DOI: 10.1016/S0140-6736(11)61097-0. View

13.

Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J . Risk factors for HCV acquisition among HIV-positive MSM in Belgium. J Acquir Immune Defic Syndr. 2015; 68(5):585-93. DOI: 10.1097/QAI.0000000000000528. View

14.

Quaranta J, Delaney S, Alleman S, Cassuto J, Dellamonica P, Allain J . Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort). J Med Virol. 1994; 42(1):29-32. DOI: 10.1002/jmv.1890420106. View

15.

Hagan H, Jordan A, Neurer J, Cleland C . Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men. AIDS. 2015; 29(17):2335-45. PMC: 4640945. DOI: 10.1097/QAD.0000000000000834. View

16.

Palacios R, Mata R, Aguilar I, Munoz L, Rios M, Vergara S . High seroprevalence but low incidence of HCV infection in a cohort of patients with sexually transmitted HIV in Andalusia, Spain. J Int Assoc Physicians AIDS Care (Chic). 2009; 8(2):100-5. DOI: 10.1177/1545109709331474. View

17.

Martin N, Hickman M, Hutchinson S, Goldberg D, Vickerman P . Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy. Clin Infect Dis. 2013; 57 Suppl 2:S39-45. PMC: 3722076. DOI: 10.1093/cid/cit296. View

18.

Nishijima T, Shimbo T, Komatsu H, Hamada Y, Gatanaga H, Oka S . Incidence and risk factors for incident Hepatitis C infection among men who have sex with men with HIV-1 infection in a large Urban HIV clinic in Tokyo. J Acquir Immune Defic Syndr. 2013; 65(2):213-7. DOI: 10.1097/QAI.0000000000000044. View

19.

Briat A, Dulioust E, Galimand J, Fontaine H, Chaix M, Letur-Konirsch H . Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin. AIDS. 2005; 19(16):1827-35. DOI: 10.1097/01.aids.0000189847.98569.2d. View

20.

Price H, Gilson R, Mercey D, Copas A, Parry J, Nardone A . Hepatitis C in men who have sex with men in London--a community survey. HIV Med. 2013; 14(9):578-80. PMC: 4016752. DOI: 10.1111/hiv.12050. View